According to CoinMeta, since Jinling Pharmaceutical submitted a "Letter of Investment Intent" to Siyao Company on April 13, 2026, the company has carried out due diligence, preliminary audits, asset evaluations, and transaction plan demonstrations in an orderly manner, and has continued to communicate and negotiate with relevant parties regarding the investment intent. Recently, the company received an "Invitation Letter" from Siyao Factory, stating that 100% of Siyao Company's equity, as well as some of its land and factory assets, are to be sold through a bidding process. Based on the "Invitation Letter" received by the company and the accompanying "Bidding Operation Guidelines," along with information already gathered earlier, after careful consideration, the company has decided not to participate in this bidding activity and has terminated the aforementioned investment intent.